**Background of ALYREF Antibody**
ALYREF (also known as THOC4 or Aly/REF export factor) is a key component of the TREX (Transcription-Export) complex, which plays a critical role in mRNA biogenesis and nuclear export. It functions as a molecular adaptor, linking the transcription machinery to mRNA export factors, ensuring proper coupling of transcription, processing, and export. ALYREF binds to spliced mRNAs, recruits the export receptor NXF1. and facilitates mRNA transport from the nucleus to the cytoplasm.
Antibodies targeting ALYREF are essential tools for studying its expression, localization, and interactions in cellular processes. They are widely used in techniques like Western blotting, immunofluorescence, and immunoprecipitation to investigate ALYREF's role in gene expression, viral RNA export, and DNA damage responses. Dysregulation of ALYREF has been implicated in cancers, including leukemia and solid tumors, where it may act as an oncogenic driver by promoting mRNA export of proliferation-related genes.
Research using ALYREF antibodies has also revealed its involvement in autoimmune diseases and viral infections, highlighting its dual role in cellular homeostasis and pathogen interactions. These antibodies enable the exploration of ALYREF as a potential therapeutic target or biomarker in disease contexts. Overall, ALYREF antibodies are vital for dissecting its multifaceted contributions to RNA metabolism and disease mechanisms.
(Word count: 199)